Literature DB >> 18473925

Multiple functions of generic drugs: future perspectives of aureolic acid group of anti-cancer antibiotics and non-steroidal anti-inflammatory drugs.

Hirak Chakraborty1, Pukhrambam Grihanjali Devi, Munna Sarkar, Dipak Dasgupta.   

Abstract

Non-steroidal anti-inflammatory drugs and aureolic acid group of anti-cancer drugs belong to the class of generic drugs. Research with some members of these two groups of drugs in different laboratories has unveiled functions other than those for which they were primarily developed as drugs. Here we have reviewed the molecular mechanism behind the multiple functions of these drugs that might lead to employ them for treatment of diseases in addition to those they are presently employed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18473925     DOI： 10.2174/138955708783955944

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN： 1389-5575            Impact factor:   3.862


  5 in total

1.  Studies of complex formation of olivomycin A and its derivatives with DNA.

Authors:  E V Andreeva; A M Vinogradov; A N Tevyashova; E N Olsufyeva; T V Burova; N V Grinberg; V Ya Grinberg; S G Skuridin; M N Preobrazhenskaya; A A Shtil; V A Kuzmin
Journal:  Dokl Biochem Biophys       Date:  2010-12-24       Impact factor: 0.788

2.  Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure.

Authors:  Sreeja Chakraborty; Esha Sehanobish; Munna Sarkar
Journal:  J Biol Inorg Chem       Date:  2012-01-20       Impact factor: 3.358

3.  Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia.

Authors:  Lorenzo Capretto; Stefania Mazzitelli; Eleonora Brognara; Ilaria Lampronti; Dario Carugo; Martyn Hill; Xunli Zhang; Roberto Gambari; Claudio Nastruzzi
Journal:  Int J Nanomedicine       Date:  2012-01-18

4.  Anticancer drug mithramycin interacts with core histones: An additional mode of action of the DNA groove binder.

Authors:  Amrita Banerjee; Sulagna Sanyal; Kirti K Kulkarni; Kuladip Jana; Siddhartha Roy; Chandrima Das; Dipak Dasgupta
Journal:  FEBS Open Bio       Date:  2014-10-16       Impact factor: 2.693

5.  Discrimination between G/C Binding Sites by Olivomycin A Is Determined by Kinetics of the Drug-DNA Interaction.

Authors:  Artemy D Beniaminov; Galina V Chashchina; Mikhail A Livshits; Olga I Kechko; Vladimir A Mitkevich; Olga K Mamaeva; Anna N Tevyashova; Alexander A Shtil; Anna K Shchyolkina; Dmitry N Kaluzhny
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.